Opinicus Capital’s Eli Lilly LLY Stock Holding History

Opinicus Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.7M	Sell	4,019 -12	-0.3%	-$12.2K	2.61%	11
2025 Q4	$4.33M	Sell	4,031 -303	-7%	-$290K	3.02%	8
2025 Q3	$3.31M	Buy	4,334 +738	+21%	+$549K	2.29%	10
2025 Q2	$2.8M	Buy	3,596 +101	+3%	+$78.5K	2.13%	10
2025 Q1	$2.89M	Sell	3,495 -129	-4%	-$107K	2.55%	9
2024 Q4	$2.8M	Sell	3,624 -83	-2%	-$68.7K	2.35%	10
2024 Q3	$3.28M	Buy	3,707 +61	+2%	+$54.8K	2.63%	9
2024 Q2	$3.3M	Buy	3,646 +21	+0.6%	+$16.8K	2.78%	9
2024 Q1	$2.82M	Buy	3,625 +40	+1%	+$28.5K	2.5%	9
2023 Q4	$2.09M	Buy	+3,585	New	+$2.09M	2.13%	11

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Opinicus Capital's LLY Position: Q1 2026 in Review

Opinicus Capital reduced its Eli Lilly (LLY) stake by 0.3% in Q1 2026, selling an estimated $12.2K and leaving 4,019 shares worth $3.7M. The position accounts for 2.61% of the portfolio, ranked #11.

Opinicus Capital first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.33M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Opinicus Capital held 4,019 shares of Eli Lilly worth $3.7M as of Q1 2026.
Opinicus Capital sold 12 Eli Lilly shares in Q1 2026, an estimated $12.2K.
Eli Lilly made up 2.61% of Opinicus Capital's portfolio in Q1 2026, its #11 holding.
Opinicus Capital first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
Opinicus Capital's Eli Lilly position peaked at $4.33M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Opinicus Capital's 13F filing for Q1 2026, filed 5 May 2026.